Hypothesis-free screening of large administrative databases for unsuspected drug-outcome associations
Active surveillance for unknown or unsuspected adverse drug effects may be carried out by applying epidemiological techniques to large administrative databases. Self-controlled designs, like the symmetry design, have the advantage over conventional design of adjusting for confounders that are stable over time. The aim of this paper was to describe the output of a comprehensive open-ended symmetry analysis of a large dataset. All drug dispensings and all secondary care contacts in Denmark during the period 1995–2012 for persons born before 1950 were analyzed by a symmetry design. We analyzed all drug–drug sequences and all drug–disease sequences occurring during the study period. The identified associations were ranked according to the number of outcomes that potentially could be attributed to the exposure. In the main analysis, 29,891,212 incident drug therapies, and 21,300,000 incident diagnoses were included. Out of 186,758 associations tested in the main analysis, 43,575 (23.3%) showed meaningful effect size. For the top 200 drug–drug associations, 47% represented unknown associations, 24% represented known adverse drug reactions, 30% were explained by mutual indication or reverse causation. For the top 200 drug–disease associations the proportions were 31, 15, and 55%, respectively. Screening by symmetry analysis can be a useful starting point for systematic pharmacovigilance activities if coupled with a systematic post-hoc review of signals.
KeywordsPharmacovigillance Pharmcoepidemiology Self-controlled design Databases Screening
Funded by Clinical Pharmacology and Pharmacy, University of Southern Denmark, Denmark and Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, MA, USA.
JH: Conceived the study, analyzed the data and wrote first draft. SVW, JJG, SS: Conceived the study, provided input to analysis and report. Nicole Pratt: Provided input to analysis and report. Anton Pottegård: Conceived the study, provided input to the report.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
- 19.Morris JA, Gardner MJ. Calculating confidence intervals for relative risks, odds ratios, and standardised ratios and rates. In: Gardner MJ, Altman DG, editors. Statistics with confidence. London: British Medical Journal Publishing; 1989. p. 60–1.Google Scholar
- 20.Cole DV, Kulldorff M, Baker M, et al. Infrastructure for evaluation of statistical alerts arising from vaccine safety data mining activities in mini-sentinel. https://www.sentinelinitiative.org/sites/default/files/Methods/Mini-Sentinel_PRISM_Data-Mining-Infrastructure_Report_0.pdf.
- 24.Lai ECC, Pottegård A, Lin SJ, Hsieh C-Y, Hallas J, Yang Y-H. Antiepileptic drugs and risk of bacterial infections: a cross-national symmetry analysis from Denmark and Taiwan (submitted).Google Scholar